Granted Patent B2

US 12,502,497 · App. 18/582,740 · Granted Dec 23, 2025

Inventors: Per Gisle Djupesland (Oslo, NO); Michael Leclerc (Cranston, RI); Ramy A Mahmoud (Skillman, NJ); Shane Siwinski (Barrington, RI); Joseph Gordon (Mansfield, MA); Justin Fisk (Providence, RI)

Assignee: OptiNose, Inc.

A61M15/08A61M15/0018A61M15/002A61M15/0021A61M15/009A61M15/0098A61M2210/0618

Abstract

Claims (24)

1 . A method of delivering a topical pharmaceutical substance to a nasal airway of a subject, comprising:

fitting a nosepiece of a delivery device to a nostril of the subject;

fitting a mouthpiece of the delivery device to an oral cavity of the subject;

wherein the delivery device includes:

a body member connecting the mouthpiece and the nosepiece and defining a fluid pathway between the mouthpiece and the nosepiece, and

a substance delivery pump at least partially contained within the body member,

the body member defining a generally annular flow channel surrounding at least a portion of the substance delivery pump, through which the exhalation breath can flow, and

the substance delivery pump containing multiple doses of the topical pharmaceutical substance;

providing a flow of exhalation breath into the mouthpiece, wherein the flow of exhalation breath into the mouthpiece is initially blocked from flowing into the body member and out of the nosepiece;

after providing the flow of exhalation breath into the mouthpiece, affecting movement of the substance delivery pump relative to the body member in a first direction by applying a force to the substance delivery pump to permit the flow of exhalation breath to flow into the body member and out of the nosepiece and, subsequent to permitting the flow of exhalation breath to flow into the body member, to expel a dose of the topical pharmaceutical substance out of the nosepiece; and

after affecting movement of the substance delivery pump relative to the body member in the first direction, affecting movement of the substance delivery pump relative to the body member in a second direction generally opposite the first direction by at least partially releasing the force applied to the substance delivery pump to block the flow of exhalation breath from flowing into the body member and out of the nosepiece.

2 . The method of claim 1 , wherein the topical pharmaceutical substance is a liquid.

3 . The method of claim 1 , wherein the topical pharmaceutical substance is a steroid.

4 . The method of claim 1 , wherein the topical pharmaceutical substance is a liquid steroid formulation.

5 . The method of claim 1 , further comprising manually moving the substance delivery pump relative to the body member to affect movement of the substance delivery pump in the first direction.

6 . The method of claim 1 , wherein the first direction is generally toward the nosepiece and the second direction is generally away from the nosepiece.

7 . The method of claim 1 , wherein the substance delivery pump is configured to expel the dose of the topical pharmaceutical substance in a period less than about 250 ms.

8 . The method of claim 1 , wherein the substance delivery pump is configured to expel the dose of the topical pharmaceutical substance in a period less than about 200 ms.

9 . The method of claim 1 , wherein the substance delivery pump is configured to expel the dose of the topical pharmaceutical substance in a period less than about 150 ms.

10 . The method of claim 1 , wherein the substance delivery pump is configured to expel the dose of the topical pharmaceutical substance in a period less than about 100 ms.

11 . The method of claim 1 , wherein the generally annular tubular flow channel defined by the nosepiece has a generally oval cross-sectional shape.

12 . The method of claim 1 , wherein a pressure of the exhalation breath provided into the mouthpiece increases in response to additional amounts of exhalation breath being provided into the mouthpiece while the flow of exhalation breath is blocked from entering the body member.

13 . The method of claim 12 , wherein the pressure of the exhalation breath provided into the mouthpiece decreases after the flow of exhalation breath is permitted to enter the body member.

14 . The method of claim 1 , wherein a flow rate of exhalation breath out of the nosepiece decreases over time after the exhalation breath is permitted to enter the body member.

Assignments (7)

Continuity (5)

References Cited (251)